Showing 181-190 of 353 results for "".
- Baby Dove Launches #BabySkin Advice on TikTok with Top Dermatologists and Pediatricianshttps://practicaldermatology.com/news/baby-dove-launches-babyskin-advice-on-tiktok-with-top-dermatologists-and-pediatricians/2461582/Baby Dove is launching #BabySkin Advice,' on TikTok The series provides expert advice from dermatologists and pediatricians to help parents in search of trusted products to care for their newborns unique and delicate skin needs. The #BabySkin Advice series will run from February 28 through March.…
- La Roche-Posay Gives Back: Brand Supports USC's Skin of Color and Pigmentary Disorders Research Fellowshiphttps://practicaldermatology.com/news/la-roche-posay-gives-back-brand-supports-uscs-skin-of-color-and-pigmentary-disorders-research-fellowship/2461558/La Roche-Posay is supporting the Skin of Color and Pigmentary Disorders Research Fellowship at the Keck School of Medicine of University of Southern California (USC). The fellowship allows students, between their third and fourth years of medical school, the opportunity to conduct research related…
- Potential Notalgia Paresthetica Breakthrough: Oral Difelikefalin May Curb Persistent Itchhttps://practicaldermatology.com/news/potential-notalgia-paresthetica-breakthrough-oral-difelikefalin-may-curb-persistent-itch/2461553/Notalgia paresthetica—a nerve disorder characterized by a persistent itch in the upper back—is a common and underdiagnosed condition worldwide. To date, there are no U.S. Food and Drug Administration (FDA)-approved treatments specifically targeting this disorder. But a new study in the New England…
- Candela Launches the All-New Profound Matrix Systemhttps://practicaldermatology.com/news/candela-launches-the-all-new-profound-matrix-system/2461544/Candela is rolling out the all-new Profound Matrix system. This multi-application system features the Sublime, Sublative radiofrequency (RF), and all-new Matrix Pro applicators. The Sublime and Sublative RF applicators deliver bipolar RF treatments that improve the appearance of fine lines and wri…
- AAD Issues Updated Guidelines for the Management of Atopic Dermatitis in Adults with Topical Therapieshttps://practicaldermatology.com/news/aad-issues-updated-guidelines-for-the-management-of-atopic-dermatitis-in-adults-with-topical-therapies/2461499/The American Academy of Dermatology (AAD) has published updated guidelines of care for the management of atopic dermatitis in adults with topical therapies in the Journal of the American Academy of Dermatology. This is the second in a series of updated guidelines the AAD is producing on the conditi…
- Promising and Consistent Topline Results Seen in Phase 3 Trial of Roflumilast in ADhttps://practicaldermatology.com/news/promising-and-consistent-topline-results-seen-in-phase-3-trial-of-roflumilast-in-ad/2461466/Arcutis Biotherapeutics, Inc.’s roflumilast met the key primary and secondary endpoints in the INTEGUMENT-2 pivotal Phase 3 trial of , adults and children 6 years and older with mild to moderate atopic dermatitis (AD). The new findings are consistent with positive topline results from the INTEGU…
- UCB’s Bimekizumab Performs Well in PsA Studieshttps://practicaldermatology.com/news/ucbs-bimekizumab-performs-well-in-psa-studies/2461460/Two new studies highlight the efficacy and safety of bimekizumab in the treatment of adults with active psoriatic arthritis who were biologic-naïve and/or tumor necrosis factor inhibitor inadequate responders (TNFi-IR). The 24-week results from the Phase 3 BE OPTIMAL study and 16-week results from…
- La Roche-Posay and the Women's Dermatologic Society Partner for Inaugural Diversity in Dermatology Fellowship at Howard Universityhttps://practicaldermatology.com/news/la-roche-posay-and-the-womens-dermatologic-society-partner-for-inaugural-diversity-in-dermatology-fellowship-at-howard-university/2461383/La Roche-Posay is partnering with the Women's Dermatologic Society (WDS) to sponsor a Fellowship in the Department of Dermatology at Howard University's College of Medicine for UIM medical students. The fellowship was created to support UIM candidates who are seeking additional clinical or research…
- Positive Topline Results from Pivotal Phase 3 Trial of Arcutis Biotherapeutics' Roflumilast Foam in Scalp and Body Psoriasishttps://practicaldermatology.com/news/positive-topline-results-from-pivotal-phase-3-trial-of-arctuis-biotherapeutics-roflumilast-foam-in-scalp-and-body-psoriasis/2461359/Topline results from the ARRECTOR Pivotal Phase 3 trial evaluating Arcutis Biotherapeutics, Inc.'s roflumilast foam 0.3% were positive for the treatment of adults and adolescents with scalp and body psoriasis. The study met its co-primary endpoints of S-IGA Success and B-IGA Success, and all second…
- Senté Launches Cysteamine HSA Pigment & Tone Correctorhttps://practicaldermatology.com/news/sente-launches-cysteamine-hsa-pigment-tone-corrector/2461301/Cysteamine HSA Pigment & Tone Corrector from Senté has launched to safely and effectively target pigmentation in all skin tones. The hydroquinone-free formula is safe for long-term use and formulated for all skin types, including dry or sensitive skin. Cysteamine HSA Pigment & Tone Corrector f…